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ABSTRACT 
Background: The thyroid gland is responsible for the production of two hormones. Those are regulating body metabolism, neurologic 
development, and numerous other body functions. So this study aimed to determine the level of serum Zinc and Manganese in Sudanese patient 
with non-cancerous thyroid disorders in Khartoum state. 
Material and Methods: This study was designed as case control, which includes 100 blood samples, a 60 from these samples were collected 
from patient with non-cancerous thyroid disorders and 40 samples were collected from health individual as control group. A total of 60 blood 
samples from the patients the males is 32 sample 53% and females is 28 sample 47%. Carried out in different Hospital in Khartoum state and 
the sample is collected by using sterile disposable syringes and separated by centrifuge, during period from March to June 2018. And the serum 
levels of zinc and manganese determined by atomic absorption spectrophotometer (OPERATOR’S MANUAL January 2003 VER 3.94 C), and the 
obtained results were analyzed by SPSS. 
Results: The study showed that there was significant different because the mean of serum Zn was 0.285 in test group and 0.720 in control 
group with p.value of 0.001 in serum level of Zn and Mn in patient compared to control subject, significant decrease in the serum levels of Zn 
and increase in Mn. Mean of Mn in test group was 0.428 and 0.406 control group with p.value of 0.006. Also the study showed the age, gender of 
the patient and duration of the disease have no effect on the serum level of Zn and Mn. 
Conclusion: This study conclude that the serum level of Zn is decrease and Mn is increase in patients with non-cancerous thyroid disorders and 
the age, gender of the patient and duration of the disease have no effect on the serum level of Zn and Mn. 
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BACKGROUND 
The thyroid gland is responsible for the production of two 
hormones: thyroid hormone and calcitonin. Calcitonin is 
secreted by parafollicular C cells and is involved in calcium 
homeostasis. Thyroid hormone is critical in regulating body 
metabolism, neurologic development, and numerous other 
body functions. Clinically, conditions affecting thyroid 
hormone levels are much more common than those affecting 
calcitonin. 1 
Thyroid hormone is critical to neurologic development of the 
fetus. Iodine is an essential component of thyroid hormone. 
In parts of the world where severe iodine deficiency exists, 
neither the mother nor the fetus can produce thyroid 
hormone and both develop hypothyroidism. Congenital 
hypothyroidism occurs in 1 of 4,000 live births. 2 If the 
mother has normal thyroid function, the fetus will be 
protected during development by small amounts of maternal 
thyroid hormone crossing the placenta. In the developed 
world, screening tests are performed on all newborns to 
diagnose congenital hypothyroidism and prevent 
catastrophic complications by the timely institution of 
thyroid hormone therapy. 
The thyroid disease may be hyperthyroidism or 
hypothyroidism. Hypothyroidism defined as a low free T4 
level with a normal or high TSH, is one of the most common 
disorders of the thyroid gland, occurring in 5%–15% of 
women over the age of 65. Symptoms of hypothyroidism 
vary, depending on the degree of hypothyroidism and the 
rapidity of its onset. When thyroid hormone is significantly 
decreased, symptoms of cold intolerance, fatigue, dry skin, 
constipation, hoarseness, dyspnea on exertion, cognitive 
dysfunction, hair loss, and weight gain have been reported. 
On physical examination, those with severe hypothyroidism 
may have low body temperature, slowed movements, 
bradycardia, delay in the relaxation phase of deep tendon 
reflexes, yellow discoloration of the skin (from 
hypercarotenemia), hair loss, diastolic hypertension, pleural 
and pericardial effusions, menstrual irregularities, and 
periorbital edema. 3 
The maintenance of optimal health requires an adequate 
supply of carbohydrates, proteins, lipid, and macronutrients, 
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micronutrients, and trace elements. 4 Many trace elements 
play an essential role in number of biological processes 
through their action as activators or inhibitors of enzymatic 
reactions, by competing with other elements and proteins for 
binding sites, by influencing the permeability of cell 
membranes, or through other mechanisms. Trace elements 
are known to influence hormone at level of action, including 
hormone secretion and activity and binding to target tissue. 
Conversely, hormones influence trace metals metabolism at 
several levels of action, including excretion and transport of 
trace metals. Hence, trace elements assay in biological fluids 
can be used as diagnostic or prognostic aid in patients with 
different hormonal disturbances alongside with other 
biochemical parameters. 5 
Thyroid hormones regulate the rate of metabolic processes 
and consequent development of organism, deficiency of 
thyroid hormones causes many metabolic processes to slow 
down. 6 Zinc is an important element for numerous 
biochemical processes as well as for cell proliferation. Zinc is 
extensively studied by bioinorganic chemistry and it is 
known that there are many metalloproteins with specific 
enzymatic activity contain zinc. Carbonic anhydrase, liver 
alcohol dehydrogenase and alkaline phosphatase are some 
examples of zinc enzyme. 7 Zinc has been shown to have an 
antioxidant effect and stabilized cell membrane. 8 Zinc is a 
metal that affects thyroid hormone function at several levels. 
For example, zinc deficiency inhibits TRH synthesis, 9 and 
depresses plasma TSH, T4, T3 (triiodothyronine). It is 
necessary for extrathyroidal T4 to T3 conversion, and it 
plays a role in T3 binding to nuclear receptor as well as the 
binding of the receptor to DNA. 10 
Manganese may affect thyroid hormone homeostasis and 
neuro developmental processes as a result of both direct 
dysregulation at the level of the thyroid gland and thyroid 
hormones, or indirectly via alterations in dopaminergic 
control of the thyroid gland and its hormones. Dopamine is a 
known modulator of both TSH and TSH subunit secretion. An 
additional effect of manganese on thyroid hormones 
homeostasis may be mediated through their metabolizing 
enzymes. Current data suggests that manganese can affect 
thyroid hormones directly by regulating the deiodinase 
enzymes. 11 
MATERIAL AND METHODS 
Case control study, this study was conducted in Khartoum 
state, in different hospital. This study was done during the 
period from March to June 2018. This study was included 
Case group: 60 Sudanese patients with non-cancerous 
thyroid disorders for different duration (less than 5 and 
more than 5years), age (27–485years) and including both 
males and females. And Control group: 40 apparently healthy 
Sudanese individuals. Volunteers enrolled in this study were 
Sudanese patient with non-cancerous thyroid disorders, also 
apparently healthy individuals as control (age matched) 
involved. All volunteers was enrolled after being fully 
informed by the aim study, more over an informed consent 
will be taken from every volunteer. One hindered blood 
specimen was included in this study. 60 of these samples 
were collected from Sudanese patient with non-cancerous 
thyroid disorders and 40 samples were collected from 
apparently healthy Sudanese individuals as control group. A 
volume of 3 ml of venous blood sample was collected from 
both cases using sterile disposable syringe and aseptic 
standard non traumatic vein puncture technique was 
applied, and emptied in a sterile plane containers. And then 
was centrifuged at 4000 rpm for 10 min, then the serum was 
separated and transferred into plain container. Separated 
serum were stored at-20ºC until analysis. This data was 
collected through interview using self-administered 
questionnaire. Collected data was computed and analyzed by 
using the application of SPSS (statistical package for social 
sciences) version 21. The test used is a T test. And the serum 
levels of Manganese and Zinc determined by the use of 
atomic absorption spectrophotometer. 
Ethical Consideration :Ethical approval was obtained from 
ethical committee of University of Shendi and Informed 
consent will be taken from all the participants prior to their 
inclusion in the study. All the procedures will inform to the 
patients in their native language and informed written 
consent will be taken from them. 
Sampling Procedure: A volume of 3 ml of venous blood 
sample was collected from both cases using sterile 
disposable syringe and aseptic standard non traumatic vein 
puncture technique was applied, and emptied in a sterile 
plane containers. And then was centrifuged at 4000 rpm for 
10 min, then the serum was separated and transferred into 
plain container. Separated serums were stored at-20ºC until 
analysis. 
Quality Control: The precision and accuracy of all methods 
use in this study were checked at each batch using 
commercially prepared control sera. 
Data analysis :Collected data was computed and analyzed 
by using the application of SPSS (statistical package for social 
sciences) version 21. The test used is a T test. 
RESULTS
 
Table 1: Comparison between the means of serum Zinc in case and in control group 
Study group Number Mean (mg/L) Std.Deviation P.value 
Case 60 0.285 0.081  
0.001 Control 40 0.720 0.137 
Table 2: Comparison between the means of serum magnesium in case and in control group 
Study group Number Mean (mg/L) Std.Deviation P.value 
Case 60 0.428 0.287  
0.006 Control 40 0.406 0.062 
Table 3: Comparison between the means of serum Zn and Mn in patients with age less than 45years and in patients with age 
more than 45 years 
Trace Element  Age P. value 
Up to 45 years More than 45 years 
Frequency  Mean (mg/L) Std.De Frequency Mean (mg/L) Std.De 
Zinc 24 0.298 0.065 36 0.279 0.09 0.216 
Manganese 24 0.387 0.27 36 0.456 0.297 0.353 
Saeed et al                                                                                                             Journal of Drug Delivery & Therapeutics. 2019; 9(2-s):497-499 
ISSN: 2250-1177                                                                                  [499]                                                                                 CODEN (USA): JDDTAO 
Table 4: Comparison between the means of serum Zn and Mn in male patients and in female patients 
Trace Element Gender P. value 
Male Female 
Frequency Mean (mg/L) Std.De Frequency Mean (mg/L) Std.De 
Zinc 32 0.282 0.89 28 0.301 0.076 0.390 
Manganese 32 0.384 0.27 28 0.464 0.29 0.475 
 
Table 5: Comparison between the means of serum Zn and Mn in patients with duration less than 5years and in patients with 
duration more than 5 years 
Trace Element Duration of disease P. value 
Up to 5 years More than 5 years 
Frequency Mean (mg/L) Std.De Frequency Mean (mg/L) Std.De 
Zinc 24 0.289 0.075 36 0.278 0.094 0.686 
Manganese 24 0.406 0.295 36 0.479 0.269 0.487 
 
Table 6: Comparison between the means of serum Zn and Mn in hyperthyroidism and in hypothyroidism 
Trace Element Thyroid disease P. value 
Hyperthyroidism Hypothyroidism 
Frequency Mean (mg/L) Std.De Frequency Mean (mg/L) Std.De 
Zinc 35 0.292 0.076 25 0.276 0.088 0.493 
Manganese 35 0.204 0.050 25 0.742 0.184 0.208 
 
DISCUSSION 
The present study was carried out to investigate trace 
element (zinc and manganese) among patient with thyroid 
disease in different Hospital, in Khartoum state in the Sudan 
during period from March to June 2018; 100 blood samples 
were collected, a 60 from these samples were collected from 
patient with thyroid disease and 40 samples were collected 
from health individual as control group. 
In the present study shown statistically significant difference 
between the mean of the serum levels of zinc and manganese 
of the test group compared with that of the control group 
(mean of Zn is 0.285 and mean of Mn was 0.428) with (P-
value = 0.001) and (P-value = 0.006) respectively, the serum 
level of zinc is decrease in case group than in control group 
(mean of case = 0.285mg/dl and control = 0.720mg/dl) and 
the serum level of manganese is increase in case group than 
in control group (mean of case = 0.428mg/dl and control = 
0.406mg/dl). That illustrated in tables 4.1 and 4.2. This agree 
with (Rebab Osman Ahmed and AbdElkarim A. Abdrabo 
2016) who were reported statically significant different in 
the serum level of zinc and manganese in the study group 
when compared with control group, the serum level of zinc is 
decrease in case group than in control group and manganese 
is increase. 
Also other similar study cared in Japan by (Yoshikazu Nishi, 
Ryosokawate and Tomofusausui 1980) agree with serum 
zinc level, who report significant decreased in serum zinc 
level in case group compared to the control group. 
The results of this study showed a non-significant difference 
between the serum levels of zinc and manganese of the test 
group according to the age (P-value = 0.216) and (P-value = 
0.353). That illustrated in table 4.3. And also according to the 
gender (P-value = 0.390) and (P-value = 0.475) respectively. 
That illustrated in table 4.4. 
Also the results of this study showed there is no significant 
difference between the serum levels of zinc and manganese 
of the test group according to the duration of disease (P-
value = 0.686) and (P-value = 0.487). That illustrated in table 
4.5. And types of thyroid disease hypo and hyperthyroidism 
(P-value = 0.493) and (P-value = 0.208). That illustrated in 
table 4.6. 
CONCLUSION 
This study concludes the serum zinc is significant low than in 
control. Serum manganese is significant high than in control. 
The age of patients have no effect on the serum levels of zinc 
and manganese. The genders of patients have no effect on 
the serum levels of zinc and manganese. The duration of 
disease have no effect on the serum levels of zinc and 
manganese. 
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